RecruitingNCT07265999

Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES

Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Enrollment

10 participants

Start Date

Jul 16, 2021

Study Type

OBSERVATIONAL

Conditions

Dermatomyositis

Summary

Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.

Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with dermatomyositis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 16 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.